PLI PLUS 2.0 is now available – click
here
to test drive the new platform.
Skip to main content
Create Account
Training Center
Contact Us
Questions? Comments?
Contact us.
Email:
PLUS@pli.edu
Phone:
877.900.5291
PLI.edu
SIGN IN
Search
Browse
All Content
Books
- Answer Books
- Course Handbooks
- Journals
- Insights
- Treatises
Forms & Checklists
Transcripts
My Bookshelf
My History
< Back To Results
1 in 13633 results
Previous Result
Next Result
Developments in Pharmaceutical and Biotech Patent Law 2017
Chair(s):
David K. Barr
Practice Area:
Biopharmaceuticals,
Biotechnology,
Intellectual property,
Life sciences,
Patents,
Pharmaceuticals
Published:
Nov 2017
i
Other versions can be found in the
Related Items
tab.
ISBN:
9781402430138
PLI Item #:
186667
CHB Spine #:
G1341
This version is not current.
Click here for the most recent version.
Search
Email
Print
Add To Bookshelf
Permalink
Table of Contents
Related Items
Select All
Front Matter
Faculty Bios
Table of Contents
Chapter 1. Ch. 14: Biologic and Biosimilar Drug Products, Practising Law Institute, Pharmaceutical and Biotech Patent Law (Prepublication Revision) (August 2017)
Chapter 2. Excerpt from Ch. 5: Patentability, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 5:4.5 [C] (November 2016)
Chapter 3. Excerpt from Ch. 7: Types of Biological and Pharmaceutical Patents, Practising Law Institute, Pharmaceutical and Biotech Patent Law § 7:7 (November 2016)
Chapter 4. Ethical Issues Confronting Life Sciences Patent Lawyers
Chapter 5. The Changing Scope of Prior Art: What’s New, What’s In, What’s Out (Substantive Outline)
Chapter 6. Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review
Chapter 7. Section 101: Patentable Subject Matter in the Aftermath of Myriad and Mayo
Index
About Us